• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Delivering Better Gut Health Supplements

    Delivering Dietary Supplements that Exceed Consumer Expectations

    Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses

    Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations

    Optimizing Gut Health: Unlocking the Gates to Well-Being
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA “Letter of No Objection” on GRAS Status

    6th Annual Dietary Supplements Regulatory Summit Scheduled for July 13

    Bunge Invests $47.5 Million in Australian Plant Proteins

    Study Finds People With Obesity are More Responsive To Food Marketing – Until Their Weight Drops

    Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA “Letter of No Objection” on GRAS Status

    Bunge Invests $47.5 Million in Australian Plant Proteins

    Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study

    Review Covers Role of Vitamin K2 in the ‘Calcium Paradox’

    KD Pharma Acquires Rohner AG Manufacturing Assets
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA “Letter of No Objection” on GRAS Status

    6th Annual Dietary Supplements Regulatory Summit Scheduled for July 13

    Bunge Invests $47.5 Million in Australian Plant Proteins

    Study Finds People With Obesity are More Responsive To Food Marketing – Until Their Weight Drops

    Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Study Finds People With Obesity are More Responsive To Food Marketing – Until Their Weight Drops

    Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study

    Review Covers Role of Vitamin K2 in the ‘Calcium Paradox’

    Thorne Healthtech and PreCon Health to Launch Supplements for Pre-, Post-Impact Brain Health

    Green Leafy Vegetable Intervention Reduces Marker of Colorectal Cancer Risk, Study Finds
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Bioenergy Life Science, Inc. (BLS)

    Gencor

    Xsto Solutions

    Aiya America (Matcha by Aiya)

    Nutrition21, LLC
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    KLK OLEO - Davos Life Science

    Verdure Sciences

    Bioenergy Life Science, Inc. (BLS)

    Xsto Solutions

    AIDP
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Federal Regulators Slam Doctors for COVID-Related Communications

    Some practitioners were not selling or promoting products, they were simply suggesting certain natural substances might offer benefits in improving resilience.

    Federal Regulators Slam Doctors for COVID-Related Communications
    Related CONTENT
    • The Next Generation Beauty-From-Within Ingredient: Lustriva
    • Innova Discusses Trends in Plant Protein Expected for 2021
    • Post COVID-19: A New World of Health & Nutrition Opportunities
    • Innova: Top Trends in Dairy Focus on Holistic Benefits
    • Unlock Possibilities for Veggie Softgel Innovation in Nutraceutical & Pharmaceutical Applications
    By Erik Goldman, Holistic Primary Care10.01.20
    If you’re reading this magazine, you probably know a thing or two about warning letters from the Food and Drug Administration and the Federal Trade Commission.

    Federal oversight and the ever-present threat of warnings are simply a part of doing business in the natural products and dietary supplements industry.

    So, it should be no surprise to you that the agencies have intensified their scrutiny in the wake of the COVID-19 pandemic. Any public health crisis of this magnitude creates a ripe situation for marketers promising quick cures and dubious defenses. With COVID-19, the huckstering began almost as soon as the virus hit our shores.

    Federal regulatory actions were equally swift. By the second week of March, the FDA had issued cease-and-desist warning letters to seven companies selling alleged COVID-19 remedies, including teas, essential oils, tinctures, and colloidal silver. The agency fired off a second wave of warnings in April. By August, FDA sent letters to nearly 100 different companies for “selling fraudulent products with claims to prevent, treat, mitigate, diagnose or cure” coronavirus.

    The FDA has also targeted “rogue online pharmacies offer[ing] potentially dangerous prescription drugs.” A catalog of Internet companies operating unlawful drug-selling operations is available on the FDA website. The FTC has been equally active, and many of the warnings were issued jointly.

    None of this is unexpected. Even in ordinary times, the FDA and FTC frequently reprimand supplement companies, pharmacies, device-makers, and food/beverage brands that market questionable products or make unsubstantiated, misleading, or inappropriate claims.

    What is new, and noteworthy, is the intensity with which the regulators—especially the FTC—are also targeting physicians and other healthcare practitioners.

    Practitioners: A New Target
    Since the pandemic began, FTC has issued unprecedented warning letters to more than 250 physicians, clinics, and companies that “promot[ed] their products and services with COVID-19 prevention or treatment claims.”

    These warnings have come in waves over the last 6 months, targeting MDs, naturopaths, chiropractors, acupuncturists, osteopaths, and non-licensed lay healthcare coaches.

    Some recipients were clearly making egregious and potentially dangerous claims about unproven, or even disproven, COVID therapies. But others were disciplined simply for posting on their practice websites or blogs about things like vitamin C or vitamin D for strengthening immune system function and warding off infections.

    Most of those who got the cease-and-desist letters were completely blind-sided; they had no idea that their patient education content could be construed by Federal officials as “commercial speech” or “marketing.”

    In some cases, the warnings contend that in making or insinuating COVID claims, these practitioners violated the Dietary Supplement Health and Education Act (DSHEA), which strictly prohibits supplement producers and marketers from making disease-related claims. This is especially true for letters sent to practitioners who sell supplements in their practices.

    To state publicly that a supplement can prevent or cure any disease is to make an unapproved drug marketing claim—even if there is research to support it. On the industry side, most responsible executives understand this. Most practitioners do not.

    A Hard Stance
    While the risk of stepping over a regulatory line is higher for practitioners who sell supplements in their practices, some of the practitioners chastised by FTC were not directly selling or promoting specific products; they were simply suggesting that certain natural substances might have benefit in improving resilience.

    In this context, the FTC is simply enforcing its very unequivocal position that currently there are no scientifically proven, FDA-approved products—pharmaceutical, nutritional, herbal, or otherwise—for preventing or treating COVID-19 or the virus that causes it.

    Therefore, any commercial language stating or insinuating such benefits is inherently unsupportable or misleading, and therefore in violation of the law.

    Part of the FTC’s mandate is to protect the public from unsubstantiated, false, or misleading advertisements. This view is summed up clearly in phrasing found in many of the warning letters:

    “It is unlawful under the FTC Act, 15 U.S.C. § 41 et seq., to advertise that a product or service can prevent, treat, or cure human disease unless you possess competent and reliable scientific evidence, including, when appropriate, well-controlled human clinical studies, substantiating that the claims are true at the time they are made. For COVID-19, no such study is currently known to exist for the services identified above. Thus, any coronavirus-related treatment or prevention claims regarding such services are not supported by competent and reliable scientific evidence.”

    One troubling feature of some of the recent warnings is that they cite general immune system claims as de facto COVID claims, even though the actual language posted by the physicians might not mention specific products, might not make definitive disease claims, or might not even use the words “COVID” or “coronavirus.”

    In the pandemic era, the agencies consider any mention of the immune system to be an implied COVID claim.

    Here are some examples of what the regulators deem transgressive online commercial speech by medical professionals. These statements are taken from actual citations in warning letters sent to practitioners in recent months:

    • “As the news surrounding COVID-19 continues to change rapidly, We at _____ clinic are doing everything in our power to ensure we ... continue to provide you with the continued care you deserve and expect during this trying time.... If you are experiencing symptoms of respiratory illness, please contact us so we may assist in providing support and treatment to aid in your recovery.”
    • “Naturopathic medicine has many useful tools for treating viruses in general, flu-like viruses in particular, fevers, as well as lung infections and cough. We utilize medicines such as homeopathy, herbal medicine, hydrotherapy, and nutrition. These remedies can make a huge difference in the course of a more serious viral infection.”
    • “We get asked ...  ‘Is there a vaccine or naturopathic cure for the coronavirus?’ At this point, there is not. You can always check the CDC website for updates on that. But what there is ... Is prevention. So let’s jump into prevention. We are really big proponents of boosting your immune system and luckily ... there are a lot of ways that you can do that.”
    • “Some safe and simple preventative immune support options to add on a daily basis include ... High-dose IV Vitamin C for super-strong immune support.”
    • “Are their ways to naturally boost my immune system? Absolutely! We have protocols we use for ourselves and for our families and our patients that have been studied to boost immune system response, and strengthen the tissue (known as mucosa) of our respiratory system.”
    Red Alert
    At face value, an FDA or FTC warning letter might not seem like a big deal. Supplement companies deal with them all the time. The letters demand that the recipient delete all the cited statements from their websites, blogs, and marketing materials within 48 hours, and report back to the agency that this has been done.

    But keep in mind that most medical practitioners are extremely risk averse, few have good understanding of FDA and FTC regulations, and even fewer have reliable legal counsel on these issues.

    Though the warning letters themselves may be fairly benign, they do enter the public record, which is constantly being trolled by class action attorneys, state attorneys general, state medical boards, and even the department of justice.

    We know of at least one case in which the FBI raided a medical doctor’s clinic to stop him from administering IV vitamin C infusions, free of charge, as a preventive or treatment for COVID. There are also reports of bank account closures of practitioners who’d received warning letters.

    This is a red alert situation. The fact that the FDA and FTC have turned their attention to medical professionals and their online communications, should concern any company doing business in the practitioner space. Historically, the regulators have shied away from directly confronting clinicians unless they were brazen in promoting products and making wild claims.

    The current practitioner warning letters indicate the agencies have revised what they consider acceptable claims. For years, the regulators treated claims like “supports a healthy immune system” to be within bounds. Not anymore.

    Michael D. Levin, a supplement industry consultant who has decades of experience in the practitioner channel said he and other natural medicine advocates are concerned that these COVID-related actions set precedents for greater restriction on other claims beyond the COVID context.

    The United Natural Products Alliance shared that anxiety. In a recent bulletin, UNPA stated that: “We have a growing concern that the FTC is working hard to push back what has been “safe” structure/function claims territory. The worst case is that this trend would now follow to other important categories, whether COVID-19 or not.”

    Three Big Questions
    In evaluating a practitioner’s online statements, regulators are considering three main things:

    • Does the statement constitute commercial speech?
    • Is the statement making a claim, and if so, what sort (disease treatment/prevention; structure/function; health promotion)?
    • Is the statement truthful, not misleading, and supportable by solid scientific evidence?
    On all three aspects, practitioners may unknowingly misstep.

    “Commercial speech,” is any communication intended to promote products or services. Judging from the recent warning letters, the FTC now views any and all statements on a medical practice’s website to be “commercial speech” in the sense that the overarching intention of the website is to promote the physician’s practice and the services or products it provides.

    There is nothing illegal or transgressive about commercial speech, so long as it is truthful. But many practitioners hold that the content they post is educational, not “commercial,” and that their prime motive is to help their patients.

    Many clinicians are unaware of the distinctions between different types of claims; they may not be aware that posting research showing that a vitamin or herb has antiviral properties could be perceived as an implied disease treatment claim, and potentially a violation of DSHEA.

    Then there’s the question of whether a claim—of whatever sort—is truthful and supportable by good evidence.

    In the context of COVID, the agencies have taken the stance that there is no definitive evidence to support claims for any product or medical intervention as a “cure” or preventive measure against COVID-19. 

    FDA and FTC do not consider anecdotal evidence, clinical experience, or clinical studies of other viral conditions to be substantial enough to support an overt or implied COVID treatment claim.

    In a webinar sponsored by the Council for Responsible Nutrition last summer, Kristi Wolff, an attorney with Kelley & Drye, LLP, a law firm specializing in nutrition industry regulation, put the situation simply.

    The FDA says: “You’re making claims to treat a disease. That is not permitted for dietary supplements.”

    The FTC says: “You need competent scientific evidence to substantiate the claim you’re making. We don’t believe you have it. Therefore, we believe you’re making fraudulent claims.”

    Concern in Congress
    There’s legislative muscle behind the recent regulatory moves. In July, the Senate Subcommittee on Manufacturing, Trade and Consumer Protection, headed by Sen. Jerry Moran (R-KS), held a hearing titled “Protecting Americans from COVID-19 Scams.“

    “During this time of national emergency and coordinated recovery, there are fraudsters and scam artists that seek to take advantage of consumers, especially the nation’s most vulnerable communities,” said Moran. “FTC’s Consumer Sentinel Network reports that consumers across the U.S. have reported over 136,000 different cases of COVID-related scams totaling approximately $90 million in total fraud losses from January 1 to July 20. These are only the reported cases. It is fair to assume that there are harmful consumer scams that have not been reported to date.”

    Moran, and others in Congress, feel they have an obligation to protect Americans from, “unsubstantiated health benefits advertised for certain products, illegal robocalls pitching low-priced health insurance, fraudulent donation solicitations, or even impostors claiming to be from federal agencies collecting mandatory payments.”

    Few in the natural products industry take issue with this stance, at least in principle.

    Back in February, a coalition representing the supplement trade associations issued a stark warning against making COVID treatment claims.

    “While research supports the use of certain dietary supplements to maintain immune system health, we are not aware of clinical research that demonstrates using a dietary supplement specifically to prevent or to treat the Novel Coronavirus,” the position statement said. “Even if research is conducted and published on the topic, the law that regulates dietary supplements [DSHEA] prohibits marketers of dietary supplements in the U.S. from promoting any dietary supplement product that makes disease prevention or treatment claims.”

    Claims vs. Clinical Communication
    At issue currently is whether a physician’s social media posts about the immune-boosting potential of medicinal mushrooms or oil of oregano, for example, constitute COVID-related disease claims or clinical communication.

    Levin said the FTC is doing its rightful job by policing commercial speech. The big problem is that most practitioners are unaware the statements they make on their clinic websites, in e-mail newsletters, or on social media posts, in fact constitute commercial speech.

    He stressed that FTC has shown no interest in regulating the protected and private speech between doctors and their patients. Direct, private, one-on-one conversations between practitioners and patients are beyond FDA and FTC jurisdiction; they fall under the rubric of “practice of medicine.” The legitimacy and veracity of what doctors say to their patients is for state medical boards (and judges in malpractice cases) to decide.

    It is the public communications—online and in print—that can trigger warning letters. But most doctors don’t know this.

    Some clinicians blind-sided by the warning letters believed they were simply offering guidance to their audience (patients and prospective patients) for improving their resilience, mitigating risk, and supporting immune function. It was ignorance of the regulations that got them in trouble, not commercial intent.

    Some practitioners, and some health advocacy groups are concerned that the warning letters foreshadow a larger, more insidious federal effort to curtail natural healthcare.

    “Your right to learn from your doctor about natural methods of staying healthy during the pandemic are under threat,” the Alliance for Natural Health warned consumers in a May statement. “The FDA, FTC, Department of Justice, and some state attorneys general have launched a coordinated censorship campaign that prevents medical doctors and other healthcare providers from communicating their extensive knowledge about how to stay healthy ... using natural medicine.”

    Finding a Middle Path
    The proliferation of fraudulent COVID cures is a real and significant problem. Equally significant and problematic is the restriction of open communication about potentially beneficial, readily-accessible, low-risk ways to boost resilience, reduce cardio-metabolic risk, and improve overall health.

    The question is how to regulate the market appropriately to protect the public from scams without penalizing practitioners who are simply trying to educate patients.

    Finding that reasonable middle path will take considerable advocacy, time, and goodwill from all parties involved.

    For now, Levin said practitioners would do well to learn the rules.

    Several medical organizations have acknowledged this need. The American Association of Naturopathic Physicians (AANP) has been very proactive on this topic, issuing numerous advisories and guidance to members, and educating them about the risks involved in commercializing or marketing the natural treatment approaches they write about in any of their patient communications.

    At Holistic Primary Care, we are working with the AANP, Levin, and other concerned stakeholders to develop an online training program that will help practitioners to stay within the bright white lines of approvable commercial speech, while maintaining their freedom of speech to help their patients.

    We have tentative participation commitments from a key member of the FTC’s regulatory staff, several attorneys familiar with these issues, and an MD who was hit with a warning letter. Watch for that later this fall.

    A number of interested parties are also working on developing disclaimer language which practitioners could post at the top of any and all COVID-related public online communications, and which could potentially reduce the odds of running afoul of the regulators.

    Many thought leaders within the practitioner channel believe a disclaimer would be a reasonable “middle path” approach to the challenge of balancing consumer protection with medical freedom of speech.

    It remains to be seen whether the FTC and FDA will see it that way. 


    Erik Goldman
    Holistic Primary Care

    Erik Goldman is co-founder and editor of Holistic Primary Care: News for Health & Healing, a quarterly medical publication reaching about 60,000 physicians and other healthcare professionals nationwide. He is also co-producer of the Practitioner Channel Forum, the nation’s leading conference focused on opportunities and challenges in the practitioner segment of the dietary supplement industry. 
    Related Searches
    • Immune Function
    • Healthcare Trends
    • Regulations
    • Dietary Supplements
    Related Knowledge Center
    • Regulations
    • Dietary Supplements
    • Immune Function
    Suggested For You
    The Next Generation Beauty-From-Within Ingredient: Lustriva The Next Generation Beauty-From-Within Ingredient: Lustriva
    Innova Discusses Trends in Plant Protein Expected for 2021 Innova Discusses Trends in Plant Protein Expected for 2021
    Post COVID-19: A New World of Health & Nutrition Opportunities Post COVID-19: A New World of Health & Nutrition Opportunities
    Innova: Top Trends in Dairy Focus on Holistic Benefits Innova: Top Trends in Dairy Focus on Holistic Benefits
    Unlock Possibilities for Veggie Softgel Innovation in Nutraceutical & Pharmaceutical Applications Unlock Possibilities for Veggie Softgel Innovation in Nutraceutical & Pharmaceutical Applications
    DR7: Next Generation Probiotic for a Healthier Gut & Brain DR7: Next Generation Probiotic for a Healthier Gut & Brain
    How Will the 2020 Election Impact the Dietary Supplement Industry? How Will the 2020 Election Impact the Dietary Supplement Industry?
    Recreational Cannabis Set to Grow to New Heights Recreational Cannabis Set to Grow to New Heights
    Native (Undenatured) Type II Collagen & Joint Health: The Latest Scientific Evidence Native (Undenatured) Type II Collagen & Joint Health: The Latest Scientific Evidence
    Transparency to Drive Innovation in 2021: Innova’s Top 10 Food & Beverage Trends Transparency to Drive Innovation in 2021: Innova’s Top 10 Food & Beverage Trends
    Poms & Associates Insurance Brokers, LLC Poms & Associates Insurance Brokers, LLC
    Gnosis, Now Acquired by Lesaffre, Announces New Business Strategy Gnosis, Now Acquired by Lesaffre, Announces New Business Strategy
    Techno Food Ingredients USA Techno Food Ingredients USA
    CBD Dog Health and Fire Flake Farm: Holistic Healing for Furry Friends CBD Dog Health and Fire Flake Farm: Holistic Healing for Furry Friends
    Preserving Quality in Immune Health Products: Weathering a Storm of Demand Preserving Quality in Immune Health Products: Weathering a Storm of Demand

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Medically Necessary Foods: Pricing & Reimbursement Considerations

      Medically Necessary Foods: Pricing & Reimbursement Considerations

      Navigating the large and growing medical foods market requires understanding key dynamics.
      By Gregory Stephens, Windrose Partners 04.08.21

    • Dietary Supplements | Regulations
      Dual Tracking of New Ingredients as Dietary Supplements and Drugs

      Dual Tracking of New Ingredients as Dietary Supplements and Drugs

      It’s possible to develop novel ingredients for both the dietary supplement and drug markets, but timing is important and there are gray areas.
      By Todd Harrison, Venable 04.08.21

    • Dietary Supplements | Probiotics & Prebiotics | Regulations | World Markets
      Probiotics & Prebiotics: The EU Ban is Shaking

      Probiotics & Prebiotics: The EU Ban is Shaking

      Some countries have not accepted the European Commission’s limitations on the term ‘probiotic’ and have implemented their own interpretations.
      By Joerg Gruenwald, analyze & realize ag 04.08.21


    • Dietary Supplements | Healthcare Trends | Immune Function | Medical Nutrition | Vitamins
      Biden COVID Response Plan Overlooks Nutrition

      Biden COVID Response Plan Overlooks Nutrition

      Our field has a unique opportunity to demonstrate the merits of our products, and the principles and philosophies behind them.
      By Erik Goldman, Holistic Primary Care 03.03.21

    • Consumer Trends | Dietary Supplements | Herbs & Botanicals | Quality & Safety
      Open Book Extracts: Innovating for Tomorrow’s Market

      Open Book Extracts: Innovating for Tomorrow’s Market

      Dave Neundorfer has a clear vision to deliver pure and consistent cannabinoids for a range of product types.
      By Sheldon Baker 03.03.21

    • Consumer Trends | Dietary Supplements | Herbs & Botanicals | Regulations
      The Evolution of Insurance for Hemp & CBD

      The Evolution of Insurance for Hemp & CBD

      Delta-8-THC is the latest wrinkle in the hemp-derived products market.
      By Chris Morey, Bolton & Company 03.03.21


    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      The Off-Label On Ramp

      The Off-Label On Ramp

      With an expanding base of clinical research supporting nutritional interventions, off label use of dietary supplements and medical foods is likely to grow.
      By Gregory Stephens, Windrose Partners, and Sheila Campbell, PhD, RD 01.19.21

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      ‘Follow the Science’ Often Misses the Mark with Nutrition

      ‘Follow the Science’ Often Misses the Mark with Nutrition

      The mantra too often ignores common sense approaches to improving health and quality of life.
      By Todd Harrison, Venable 01.19.21

    • Dietary Supplements | Herbs & Botanicals | Regulations | World Markets
      CBD in Europe: News from the Front

      CBD in Europe: News from the Front

      A recent decision by the Court of Justice of the European Union has restored CBD’s status, and with it, the prospects of the entire industry.
      By Joerg Gruenwald, analyze & realize ag 01.19.21


    • Cardiovascular Health | Herbs & Botanicals | Immune Function | Research | Weight Management/Weight Loss
      Botanical Research: Botanicals & Immunity, Kava Challenges, Turmeric Therapeutics and More

      Botanical Research: Botanicals & Immunity, Kava Challenges, Turmeric Therapeutics and More

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly Johnson, PhD, American Herbal Products Association (AHPA) 01.19.21

    • Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Quality & Safety
      The Advantages of Organic, Broad Spectrum Hemp

      The Advantages of Organic, Broad Spectrum Hemp

      Mike Hennesy, Wana Brands, discusses the company’s new gummies, innovation, and continuing market evolution.
      By Sheldon Baker 12.04.20

    • Dietary Supplements | Regulations
      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Companies can be prepared by being thorough and transparent while going through insurance policy renewals.
      By Chris Morey, Bolton & Company 12.04.20


    • Dietary Supplements | Regulations
      A Business Perspective on Protecting Confidential Information: The NDA

      A Business Perspective on Protecting Confidential Information: The NDA

      Along with taking precautions in providing access to confidential information, a non-disclosure agreement can be a great way to protect your business.
      By Gregory Stephens, Windrose Partners 11.09.20

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations | Research | Vitamins
      Using All the Tools to Improve Public Health

      Using All the Tools to Improve Public Health

      Industry needs to make a stand in compelling authorities to communicate the value of nutrition and dietary supplementation.
      By Todd Harrison, Venable 11.09.20

    • Dietary Supplements | Regulations | World Markets
      Regulation Changes Calculus for Substance-Based Medical Devices

      Regulation Changes Calculus for Substance-Based Medical Devices

      The new regulation introduces more specific requirements for the technical documentation of this class of products.
      By Joerg Gruenwald, analyze & realize ag 11.09.20

    Trending
    • CGA-7 Green Coffee Extract By Vidya Herbs Achieves Self-Affirmed GRAS Status
    • Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass In Older Adults
    • Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection In Recent Study
    • Innovative Probiotic Launches
    • Kyowa Hakko Launches Heat-Treated Probiotic Strain For Eye Health
    Breaking News
    • BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA “Letter of No Objection” on GRAS Status
    • 6th Annual Dietary Supplements Regulatory Summit Scheduled for July 13
    • Bunge Invests $47.5 Million in Australian Plant Proteins
    • Study Finds People With Obesity are More Responsive To Food Marketing – Until Their Weight Drops
    • Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Optimizing Gut Health: Unlocking the Gates to Well-Being
    • Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations
    • Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses
    • Delivering Dietary Supplements that Exceed Consumer Expectations
    • Delivering Better Gut Health Supplements
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA “Letter of No Objection” on GRAS Status
    6th Annual Dietary Supplements Regulatory Summit Scheduled for July 13
    Bunge Invests $47.5 Million in Australian Plant Proteins
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    VideoBite: Engineered Polymer Solutions
    Shepherd Color Unveils Bismuth Vanadate Yellow Pigment
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Medtronic Introduces Extended Infusion Set in Europe
    BioSig Launches Software Update for PURE EP Electrophysiology Platform
    Katena Acquires Ophthalmic Surgical Instrument Maker ASICO
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioVersys Gets EIB Funds to Address Antimicrobial Resistance
    Microbiologics Expands Virology Services
    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Cosmoprof Worldwide Bologna Postpones 2021 Show
    Native Launches Broad Spectrum SPF 30 Mineral Sunscreens
    Revieve Launches Skin Coach
    Happi

    Latest Breaking News From Happi

    Hallstar Beauty Names New President
    The Fragrance Foundation Announces the 2021 Awards Finalists
    Azelis Earns 'Coup de Coeur' Award at Cosmetagora 2021
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Epson SurePress reaches milestone
    Maxcess updates user interface for Fife guiding Sensor
    Bobst announces virtual packaging industry event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    PCMC Redesigns Rx200 and Mako Clipper Wet Wipes Machines
    PFNonwovens Adding New Capabilities in Znojmo
    Russ Torres Named Group President of Kimberly-Clark North America
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Biogennix Rolls Out Agilon Strip Bone Graft
    Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations
    SUPERSMART Wins 'Best Publicly Funded Project Demonstrator' in 2021 OE-A Competition

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login